Loading…

Browse All Grants

606,025 grants found

Filters
Reset

Showing 9,5819,600 of 606,025 grants

Active PROJECT GRANT SEK
Genetics of preterm delivery and its cellular mechanisms: beyond genomics discoveries
Swedish Research Council University of Gothenburg Sweden 2025 – 2028

Preterm delivery is the leading cause of death in children under 5-years of age and long-term child morbidity.The preterm delivery rate has not shown any notable reduction, partly...

56M kr
SEK
Active GRANT FOR POSITIONS OR STIPENDS SEK
Accessing regional health data for the study of multiple sclerosis: From predictors to precision medicine
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

Multiple sclerosis (MS) is a chronic disabling disease of the brain and spinal cord with an unknown aetiology.In recent years, researchers have discovered a ‘prodromal’ period befo...

60M kr
SEK
Active PROJECT GRANT SEK
Changes in chromosome numbers in pediatric leukemia: how, why and when?
Swedish Research Council Lund University Sweden 2025 – 2028

Aneuploidy, i.e., changes in chromosome numbers, is a common phenomenon in cancer cells.In the proposed project I will study two types of aneuploid pediatric acute lymphoblastic le...

56M kr
SEK
Active GRANT FOR POSITIONS OR STIPENDS SEK
Illuminating neutrophils dark microproteome against fungal pathogens
Swedish Research Council Umeå University Sweden 2025 – 2028

The human genome contains thousands of unannotated short open reading frame (sORF) encoded microproteins, which are potential functional peptides waiting to be discovered.Despite t...

60M kr
SEK
Active GRANT FOR POSITIONS OR STIPENDS SEK
Cellular and Molecular mapping of the blood nerve barrier during health and disease
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

The entire central and peripheral nervous systems (CNS and PNS) are shielded from potentially neurotoxic molecules in the circulation by the blood-brain and blood-nerve barriers.Do...

60M kr
SEK
Active PROJECT GRANT SEK
Frizzleds as dynamic, pharmacological and druggable entities
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

Diverse signaling systems are attractive targets for anti-cancer therapy, one of which is the WNT/Frizzled signaling system, where secreted WNT proteins activate Frizzled receptors...

56M kr
SEK
Active GRANT FOR POSITIONS OR STIPENDS SEK
Spatial and single-cell proteomics of metabolic disorders
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

Mitochondrial metabolism is constrained by the available resources within its host cells and surrounding tissue.Enzymatic sets are dynamically expressed upon internal and external...

60M kr
SEK
Active PROJECT GRANT SEK
Common factors contributing to poor reproductive outcome from failed implantation to pregnancy loss
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

Motherhood holds a profound significance for many women, yet one in six couples encounters infertility. In vitro fertilization (IVF), the most common treatment, yields modest pregn...

56M kr
SEK
Active PROJECT GRANT SEK
Visualizing evolution of resistance in breast cancer tumors through In Situ Sequencing
Swedish Research Council Stockholm University Sweden 2025 – 2028

Intratumoral heterogeneity is a critical driver of tumor resistance, as varying populations of cancer cells within a tumor can exhibit different sensitivities to treatments.This dy...

56M kr
SEK
Active PROJECT GRANT SEK
Alkoholbruk trots negativa konsekvenser: En translationell strategi
Swedish Research Council Linköping University Sweden 2025 – 2029

Alcohol addiction leads to continued alcohol use despite adverse consequences (“compulsivity”).We have found that a minority of outbred rats show punishment-resistant, compulsive-l...

100M kr
SEK
Active PROJECT GRANT SEK
Receptor-mediated mechanisms in Parkinson´s disease and depression
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

This programme aims at providing better biomarkers anbd mechanism-based therapies for two common diseases: Parkinson´s disease (PD) and Major depressive disorder (MDD). Besides mot...

56M kr
SEK
Active PROJECT GRANT SEK
Mechanisms of antiviral defense in the CNS - uncovered through patient-mimicking transgenic mice and human brain organoids
Swedish Research Council University of Gothenburg Sweden 2025 – 2027

Viral infections can cause devastating diseases if not controlled by the immune system.This includes diseases in the central nervous system (CNS) where e.g. herpes simplex virus 2...

42M kr
SEK
Active PROJECT GRANT SEK
Building Bone: Harnessing Fetal Mesenchymal Stem Cells to Treat Osteogenesis Imperfecta.
Swedish Research Council Karolinska Institutet Sweden 2025 – 2027

Our aim is to harness the full potential of our recently developed fetal mesenchymal stem cell (fMSC) therapy.We are currently about to change the lives of people living with Osteo...

42M kr
SEK
Active PROJECT GRANT SEK
The significance of environmental and lifestyle factors for the onset and course of multiple sclerosis.
Swedish Research Council Karolinska Institutet Sweden 2025 – 2027

Multiple sclerosis (MS) is the leading cause of non-traumatic neurological disability in young adults in Europe. The etiology is unclear. Twin studies suggest that environment and/...

30M kr
SEK
Active GRANT FOR POSITIONS OR STIPENDS SEK
BEAM-MS - Brain-resident cell Epigenetics Altered by the Metabolome to target Multiple Sclerosis
Swedish Research Council Karolinska Institutet Sweden 2025 – 2028

Multiple Sclerosis (MS) is a major neurological disorder, characterized by the loss of myelin around nerve axons in the central nervous system due to autoimmune attacks.Oligodendro...

60M kr
SEK
Active PROJECT GRANT SEK
To find the cause of rheumatoid arthritis using humanized mouse models with the major polymorphic genes; HLA-DR and NCF1
Swedish Research Council Karolinska Institutet Sweden 2025 – 2029

Purpose and objective: Investigate the cause of rheumatoid arthritis (RA) using unique mouse strains expressing the major disease-associated human alleles (DRB1 and NCF1) to develo...

100M kr
SEK
Active PROJECT GRANT SEK
IL-6 trans-signalling in HPS and HFRS pathogenesis: a treatable target?
Swedish Research Council Linköping University Sweden 2025 – 2027

Hantaviruses cause two severe acute diseases; hantavirus pulmonary syndrome (HPS), and hemorrhagic fever with renal syndrome (HFRS). Fatality rates are 35-40% for HPS and up to 10%...

42M kr
SEK
Active PROJECT GRANT SEK
Pathogenic mechanisms and effects of treatment in chronic, idiopathic inflammatory myopathies, myositis
Swedish Research Council Karolinska Institutet Sweden 2025 – 2027

Myositis is a complex autoimmune disease with high morbidity and mortality. Biomarkers to predict prognosis are lacking.Newly discovered myositis specific autoantibodies predict di...

30M kr
SEK
Active PROJECT GRANT SEK
Understanding how MYC drives transcriptional amplification via regulation of DNA topology
Swedish Research Council Karolinska Institutet Sweden 2025 – 2029

Inhibitors of Topoisomerases (TOPs, TOP1, TOP2) are mainstays of anticancer therapy. While they have proven effective, the toxicity of current TOP drugs in non-cancer cells, limits...

100M kr
SEK
Active PROJECT GRANT SEK
Towards personalized medicine in pregnancy: Early prediction of pregnancy complications to improve maternal and fetal outcomes
Swedish Research Council Uppsala University Sweden 2025 – 2028

Purpose.The existing antenatal care program is similar for most women with increasing frequency of visits as the pregnancy progresses, aiming to find established pregnancy complica...

56M kr
SEK